Authors: Bhavnani, SM Ballow, CH

Citation: Sm. Bhavnani et Ch. Ballow, New agents for Gram-positive bacteria, CURR OPIN M, 3(5), 2000, pp. 528-534

Authors: Moise, PA Forrest, A Bhavnani, SM Birmingham, MC Schentag, JJ

Citation: Pa. Moise et al., Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus, AM J HEAL S, 57(20), 2000, pp. S4-S9

Authors: Bhavnani, SM

Citation: Sm. Bhavnani, Benchmarking in health-system pharmacy: Current research and practical applications, AM J HEAL S, 57(20), 2000, pp. S13-S20

Authors: Paladino, JA Bhavnani, SM Schentag, JJ

Citation: Ja. Paladino et al., Costs and bacterial susceptibility after therapeutic interchange of fluoroquinolones, AM J HEAL S, 57(18), 2000, pp. 1712-1712

Authors: Bhavnani, SM Drake, JA Forrest, A Deinhart, JA Jones, RN Biedenbach, DJ Ballow, CH

Citation: Sm. Bhavnani et al., A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia, DIAG MICR I, 36(3), 2000, pp. 145-158

Authors: Rifenburg, RP Paladino, JA Bhavnani, SM Den Haese, D Schentag, JJ

Citation: Rp. Rifenburg et al., Influence of fluoroquinolone purchasing patterns on antimicrobial expenditures and Pseudomonas aeruginosa susceptibility, AM J HEAL S, 56(21), 1999, pp. 2217-2223